Research and Markets
This Vitacon Drug Valuation Model is an Excel Spreadsheet Model That is Intended as an Asset Valuation and Transaction Strategy Tool for the Biopharmaceutical Industry
Published in Lab Law Weekly, August 7th, 2009
The 'Vitacon Drug Valuation Model' is an Excel spreadsheet model that is intended to be used as an asset valuation and transaction strategy tool for the biopharmaceutical industry.
Analyze the risk-adjusted value of your new drug using a sensible number of input estimates and explore the deal structure that could satisfy any one of three starting points for a licensing bid.
With the Vitacon Drug Valuation Model , you can assess the risk-adjusted...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
Source: Lab Law Weekly (2009-08-07)
More Articles from Lab Law Weekly
- A.P. Pharma, Inc.
A.P. Pharma Receives Nasdaq Notice of Non-Compliance; Company to Request Hearing - AAUW
AAUW Supports Confirmation of Judge Sotomayor - Acacia Research Corporation
Acacia Research Reports Second Quarter 2009 Financial Results - Addus HomeCare Corporation
Addus HomeCare Corporation Files Registration Statement - Agile IP
Agile IP Protects RedZebra's 'Tamper Proof' Pictures - American Academy of Actuaries
Actuaries: Federal Long-Term Care Legislation Falls Short on Coverage Goals - More from this issue of Lab Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
